🔎 Trials Near Me

Hjem › Migræne › Ohio

Migræne kliniske forsøg i Ohio

13 studier for Migræne søger deltagere på steder i Ohio.

Byer i Ohio

Officiel studietekst (engelsk)

Study of EVO756 in Adults With Migraine

  • NeuroScience Research Center, Canton
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

  • Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1
Alder 6 til 11 · Alle køn · Opdateret 28. sep. 2026 · NCT06995729

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 28. sep. 2026 · NCT05156398

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Cincinnati Children's Hospital, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242

Responding With Evidence and Access for Childhood Headaches

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Childrens, Columbus
Rekrutterer
Alder 10 til 17 · Alle køn · Opdateret 21. sep. 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Ohio State University Wexner Medical Center, Columbus
RekruttererFase 4
Alder 18 til 70 · Alle køn · Opdateret 16. sep. 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
  • University Of Cincinnati Medical Center /ID# 231199, Cincinnati
  • Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
  • og 3 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Hometown Research, Columbus
  • Hometown Research, Milford
  • CincyScience, West Chester
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924

BE WELL With Migraine: Brain Education and WELLness With Migraine

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT05987592

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

  • Childrens Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 12. jun. 2026 · NCT05164172

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

  • Upsher-Smith Clinical Trial Site #4, Cincinnati
RekruttererFase 4
Alder 6 til 11 · Alle køn · Opdateret 27. jan. 2025 · NCT04748601

Overlapping Pain Trajectory Study

  • Cincinnati Children's Hospital, Cincinnati
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 10 til 19 · Alle køn · Opdateret 22. aug. 2024 · NCT05752396

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.